Inactive Instrument

Insiders GTx, Inc. Nasdaq

Equities

Oncternal Therapeutics, Inc. Appoints Damien Bresson as Senior Director, Preclinical and Translation Science	Feb. 01	CI
Oncternal Therapeutics, Inc. Adds Matthew Smith to its Prostate Cancer Scientific Advisory Board	23-10-25	CI
Oncternal Therapeutics, Inc. Announces Resignation of Gunnar Kaufmann as Chief Scientific Officer, Effective June 14, 2023	23-06-02	CI
Oncternal Therapeutics, Inc. Appoints Jill DeSimone to the Board of Directors	23-01-04	CI
Oncternal Therapeutics, Inc. Announces the Resignation of Jinzhu Chen from the Board of Directors	22-12-23	CI
Oncternal Therapeutics, Inc. Announces Board Appointments	21-11-02	CI
Oncternal Therapeutics, Inc. Appoints Pablo Urbaneja as Senior Vice President, Corporate Development	21-07-02	CI
Oncternal Therapeutics, Inc. Elects Jinzhu Chen as Class II Director	21-05-28	CI
Oncternal Therapeutics, Inc. Announces Appointment of Salim Yazji as Chief Medical Officer	21-05-17	CI
Oncternal Therapeutics Announces Appointment of Chase Leavitt as General Counsel	21-04-12	CI
Oncternal Therapeutics, Inc. Appoints Rosemary Mazanet as a Class I Director	21-01-28	CI
Hazel M. Aker Intends to Retire as General Counsel of Oncternal Therapeutics, Inc., Effective August 15, 2020	20-07-31	CI
Oncternal Therapeutics, Inc. Announces Board Changes	19-12-23	CI
Oncternal Therapeutics, Inc. Announces Executive Appointments	19-09-09	CI
Oncternal Therapeutics, Inc. Announces Management Appointments	19-08-28	CI
Oncternal Therapeutics, Inc. Announces Additions to the Board of Directors	18-04-03	CI

No results for this search